 | • レポートコード：QYR2104Z0942 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、153ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、骨肉腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（放射線療法、化学療法、外科的治療、凍結手術、薬物）、用途別市場規模（びまん性骨肉腫、結節性骨肉腫、壊死性骨肉腫、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・骨肉腫治療の市場動向 ・企業の競争状況、市場シェア ・骨肉腫治療の種類別市場規模（放射線療法、化学療法、外科的治療、凍結手術、薬物） ・骨肉腫治療の用途別市場規模（びまん性骨肉腫、結節性骨肉腫、壊死性骨肉腫、その他） ・骨肉腫治療の北米市場規模2016-2027（アメリカ、カナダ） ・骨肉腫治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・骨肉腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・骨肉腫治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・骨肉腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bayer AG、Amgen、Novartis AG、Pfizer、AstraZeneca、Dr. Reddy's Laboratories (DRL)、Actavis、Bristol-Myers Squibb、Celgene Corporation、Eli Lilly、Roche、GlaxoSmithKline、Sanofi、Amneal Pharmaceuticals LLC、Baxter International、BoehringerIngelheim、Fresenius Kabi、Jubilant Cadista Pharmaceuticals、Mylan Pharmaceuticals、Perrigo Company、Roxane Laboratories、Sandoz、Henlius Biotech、Teva Pharmaceuticals USA、West-Ward Pharmaceuticals、Zydus Pharmaceuticals (Cadila Healthcare)） ・結論 |
There are diagnostic tests and treatment steps for bone cancer, starting with ultrasound, a CBC, biopsy, and other diagnostic tests.They were then treated with drugs such as corticosteroids, non-steroidal anti-inflammatory drugs and immunosuppressants and surgery.Corticosteroids include difluprednisolone, prednisolone, etc.Non-steroidal anti-inflammatory drugs include aspirin, ibuprofen, etc.Immunosuppressive drugs include methotrexate, mycophenolate, etc.
Market Analysis and Insights: Global Bone Cancer Treatment Market
The global Bone Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bone Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bone Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bone Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bone Cancer Treatment market.
Global Bone Cancer Treatment Scope and Market Size
Bone Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bone Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Radiation Therapy
Chemotherapy
Surgical Treatments
Cryosurgery
Drugs
Segment by Application
Diffuse Bone Cancer
Nodular Bone Cancer
Necrotizing Bone Cancer
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Bayer AG
Amgen
Novartis AG
Pfizer
AstraZeneca
Dr. Reddy’s Laboratories (DRL)
Actavis
Bristol-Myers Squibb
Celgene Corporation
Pfizer
AstraZeneca
GlaxoSmithKline
Sanofi
Amneal Pharmaceuticals LLC
Baxter International
BoehringerIngelheim
Fresenius Kabi
Jubilant Cadista Pharmaceuticals
Mylan Pharmaceuticals
Perrigo Company
Roxane Laboratories
Sandoz
Henlius Biotech
Teva Pharmaceuticals USA
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bone Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Radiation Therapy
1.2.3 Chemotherapy
1.2.4 Surgical Treatments
1.2.5 Cryosurgery
1.2.6 Drugs
1.3 Market by Application
1.3.1 Global Bone Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diffuse Bone Cancer
1.3.3 Nodular Bone Cancer
1.3.4 Necrotizing Bone Cancer
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bone Cancer Treatment Market Perspective (2016-2027)
2.2 Bone Cancer Treatment Growth Trends by Regions
2.2.1 Bone Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bone Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Bone Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Bone Cancer Treatment Industry Dynamic
2.3.1 Bone Cancer Treatment Market Trends
2.3.2 Bone Cancer Treatment Market Drivers
2.3.3 Bone Cancer Treatment Market Challenges
2.3.4 Bone Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bone Cancer Treatment Players by Revenue
3.1.1 Global Top Bone Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Bone Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Bone Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bone Cancer Treatment Revenue
3.4 Global Bone Cancer Treatment Market Concentration Ratio
3.4.1 Global Bone Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bone Cancer Treatment Revenue in 2020
3.5 Bone Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Bone Cancer Treatment Product Solution and Service
3.7 Date of Enter into Bone Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bone Cancer Treatment Breakdown Data by Type
4.1 Global Bone Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Bone Cancer Treatment Forecasted Market Size by Type (2022-2027)
5 Bone Cancer Treatment Breakdown Data by Application
5.1 Global Bone Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Bone Cancer Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Bone Cancer Treatment Market Size (2016-2027)
6.2 North America Bone Cancer Treatment Market Size by Type
6.2.1 North America Bone Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Bone Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Bone Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Bone Cancer Treatment Market Size by Application
6.3.1 North America Bone Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Bone Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Bone Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Bone Cancer Treatment Market Size by Country
6.4.1 North America Bone Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Bone Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Bone Cancer Treatment Market Size (2016-2027)
7.2 Europe Bone Cancer Treatment Market Size by Type
7.2.1 Europe Bone Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Bone Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Bone Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Bone Cancer Treatment Market Size by Application
7.3.1 Europe Bone Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Bone Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Bone Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Bone Cancer Treatment Market Size by Country
7.4.1 Europe Bone Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Bone Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Bone Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Bone Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Bone Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bone Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bone Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Bone Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Bone Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bone Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bone Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Bone Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Bone Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bone Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Bone Cancer Treatment Market Size (2016-2027)
9.2 Latin America Bone Cancer Treatment Market Size by Type
9.2.1 Latin America Bone Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Bone Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Bone Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Bone Cancer Treatment Market Size by Application
9.3.1 Latin America Bone Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Bone Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Bone Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Bone Cancer Treatment Market Size by Country
9.4.1 Latin America Bone Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Bone Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bone Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Bone Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Bone Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bone Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bone Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Bone Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Bone Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bone Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bone Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Bone Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Bone Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bone Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Bone Cancer Treatment Introduction
11.1.4 Bayer AG Revenue in Bone Cancer Treatment Business (2016-2021)
11.1.5 Bayer AG Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Bone Cancer Treatment Introduction
11.2.4 Amgen Revenue in Bone Cancer Treatment Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Bone Cancer Treatment Introduction
11.3.4 Novartis AG Revenue in Bone Cancer Treatment Business (2016-2021)
11.3.5 Novartis AG Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Bone Cancer Treatment Introduction
11.4.4 Pfizer Revenue in Bone Cancer Treatment Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Bone Cancer Treatment Introduction
11.5.4 AstraZeneca Revenue in Bone Cancer Treatment Business (2016-2021)
11.5.5 AstraZeneca Recent Development
11.6 Dr. Reddy’s Laboratories (DRL)
11.6.1 Dr. Reddy’s Laboratories (DRL) Company Details
11.6.2 Dr. Reddy’s Laboratories (DRL) Business Overview
11.6.3 Dr. Reddy’s Laboratories (DRL) Bone Cancer Treatment Introduction
11.6.4 Dr. Reddy’s Laboratories (DRL) Revenue in Bone Cancer Treatment Business (2016-2021)
11.6.5 Dr. Reddy’s Laboratories (DRL) Recent Development
11.7 Actavis
11.7.1 Actavis Company Details
11.7.2 Actavis Business Overview
11.7.3 Actavis Bone Cancer Treatment Introduction
11.7.4 Actavis Revenue in Bone Cancer Treatment Business (2016-2021)
11.7.5 Actavis Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Bone Cancer Treatment Introduction
11.8.4 Bristol-Myers Squibb Revenue in Bone Cancer Treatment Business (2016-2021)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Celgene Corporation
11.9.1 Celgene Corporation Company Details
11.9.2 Celgene Corporation Business Overview
11.9.3 Celgene Corporation Bone Cancer Treatment Introduction
11.9.4 Celgene Corporation Revenue in Bone Cancer Treatment Business (2016-2021)
11.9.5 Celgene Corporation Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Bone Cancer Treatment Introduction
11.10.4 Eli Lilly Revenue in Bone Cancer Treatment Business (2016-2021)
11.10.5 Eli Lilly Recent Development
11.11 Roche
11.11.1 Roche Company Details
11.11.2 Roche Business Overview
11.11.3 Roche Bone Cancer Treatment Introduction
11.11.4 Roche Revenue in Bone Cancer Treatment Business (2016-2021)
11.11.5 Roche Recent Development
11.12 GlaxoSmithKline
11.12.1 GlaxoSmithKline Company Details
11.12.2 GlaxoSmithKline Business Overview
11.12.3 GlaxoSmithKline Bone Cancer Treatment Introduction
11.12.4 GlaxoSmithKline Revenue in Bone Cancer Treatment Business (2016-2021)
11.12.5 GlaxoSmithKline Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Bone Cancer Treatment Introduction
11.13.4 Sanofi Revenue in Bone Cancer Treatment Business (2016-2021)
11.13.5 Sanofi Recent Development
11.14 Amneal Pharmaceuticals LLC
11.14.1 Amneal Pharmaceuticals LLC Company Details
11.14.2 Amneal Pharmaceuticals LLC Business Overview
11.14.3 Amneal Pharmaceuticals LLC Bone Cancer Treatment Introduction
11.14.4 Amneal Pharmaceuticals LLC Revenue in Bone Cancer Treatment Business (2016-2021)
11.14.5 Amneal Pharmaceuticals LLC Recent Development
11.15 Baxter International
11.15.1 Baxter International Company Details
11.15.2 Baxter International Business Overview
11.15.3 Baxter International Bone Cancer Treatment Introduction
11.15.4 Baxter International Revenue in Bone Cancer Treatment Business (2016-2021)
11.15.5 Baxter International Recent Development
11.16 BoehringerIngelheim
11.16.1 BoehringerIngelheim Company Details
11.16.2 BoehringerIngelheim Business Overview
11.16.3 BoehringerIngelheim Bone Cancer Treatment Introduction
11.16.4 BoehringerIngelheim Revenue in Bone Cancer Treatment Business (2016-2021)
11.16.5 BoehringerIngelheim Recent Development
11.17 Fresenius Kabi
11.17.1 Fresenius Kabi Company Details
11.17.2 Fresenius Kabi Business Overview
11.17.3 Fresenius Kabi Bone Cancer Treatment Introduction
11.17.4 Fresenius Kabi Revenue in Bone Cancer Treatment Business (2016-2021)
11.17.5 Fresenius Kabi Recent Development
11.18 Jubilant Cadista Pharmaceuticals
11.18.1 Jubilant Cadista Pharmaceuticals Company Details
11.18.2 Jubilant Cadista Pharmaceuticals Business Overview
11.18.3 Jubilant Cadista Pharmaceuticals Bone Cancer Treatment Introduction
11.18.4 Jubilant Cadista Pharmaceuticals Revenue in Bone Cancer Treatment Business (2016-2021)
11.18.5 Jubilant Cadista Pharmaceuticals Recent Development
11.18 Mylan Pharmaceuticals
11.25.1 Mylan Pharmaceuticals Company Details
11.25.2 Mylan Pharmaceuticals Business Overview
11.25.3 Mylan Pharmaceuticals Bone Cancer Treatment Introduction
11.25.4 Mylan Pharmaceuticals Revenue in Bone Cancer Treatment Business (2016-2021)
11.25.5 Mylan Pharmaceuticals Recent Development
11.20 Perrigo Company
11.20.1 Perrigo Company Company Details
11.20.2 Perrigo Company Business Overview
11.20.3 Perrigo Company Bone Cancer Treatment Introduction
11.20.4 Perrigo Company Revenue in Bone Cancer Treatment Business (2016-2021)
11.20.5 Perrigo Company Recent Development
11.21 Roxane Laboratories
11.21.1 Roxane Laboratories Company Details
11.21.2 Roxane Laboratories Business Overview
11.21.3 Roxane Laboratories Bone Cancer Treatment Introduction
11.21.4 Roxane Laboratories Revenue in Bone Cancer Treatment Business (2016-2021)
11.21.5 Roxane Laboratories Recent Development
11.22 Sandoz
11.22.1 Sandoz Company Details
11.22.2 Sandoz Business Overview
11.22.3 Sandoz Bone Cancer Treatment Introduction
11.22.4 Sandoz Revenue in Bone Cancer Treatment Business (2016-2021)
11.22.5 Sandoz Recent Development
11.23 Henlius Biotech
11.23.1 Henlius Biotech Company Details
11.23.2 Henlius Biotech Business Overview
11.23.3 Henlius Biotech Bone Cancer Treatment Introduction
11.23.4 Henlius Biotech Revenue in Bone Cancer Treatment Business (2016-2021)
11.23.5 Henlius Biotech Recent Development
11.24 Teva Pharmaceuticals USA
11.24.1 Teva Pharmaceuticals USA Company Details
11.24.2 Teva Pharmaceuticals USA Business Overview
11.24.3 Teva Pharmaceuticals USA Bone Cancer Treatment Introduction
11.24.4 Teva Pharmaceuticals USA Revenue in Bone Cancer Treatment Business (2016-2021)
11.24.5 Teva Pharmaceuticals USA Recent Development
11.25 West-Ward Pharmaceuticals
11.25.1 West-Ward Pharmaceuticals Company Details
11.25.2 West-Ward Pharmaceuticals Business Overview
11.25.3 West-Ward Pharmaceuticals Bone Cancer Treatment Introduction
11.25.4 West-Ward Pharmaceuticals Revenue in Bone Cancer Treatment Business (2016-2021)
11.25.5 West-Ward Pharmaceuticals Recent Development
11.26 Zydus Pharmaceuticals (Cadila Healthcare)
11.26.1 Zydus Pharmaceuticals (Cadila Healthcare) Company Details
11.26.2 Zydus Pharmaceuticals (Cadila Healthcare) Business Overview
11.26.3 Zydus Pharmaceuticals (Cadila Healthcare) Bone Cancer Treatment Introduction
11.26.4 Zydus Pharmaceuticals (Cadila Healthcare) Revenue in Bone Cancer Treatment Business (2016-2021)
11.26.5 Zydus Pharmaceuticals (Cadila Healthcare) Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Bone Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Radiation Therapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Surgical Treatments
Table 5. Key Players of Cryosurgery
Table 6. Key Players of Drugs
Table 7. Global Bone Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Bone Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Bone Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Bone Cancer Treatment Market Share by Regions (2016-2021)
Table 11. Global Bone Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Bone Cancer Treatment Market Share by Regions (2022-2027)
Table 13. Bone Cancer Treatment Market Trends
Table 14. Bone Cancer Treatment Market Drivers
Table 15. Bone Cancer Treatment Market Challenges
Table 16. Bone Cancer Treatment Market Restraints
Table 17. Global Bone Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Bone Cancer Treatment Market Share by Players (2016-2021)
Table 19. Global Top Bone Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bone Cancer Treatment as of 2020)
Table 20. Ranking of Global Top Bone Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Bone Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Bone Cancer Treatment Product Solution and Service
Table 24. Date of Enter into Bone Cancer Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Bone Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Bone Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Bone Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Bone Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Bone Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Bone Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Bone Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Bone Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Bone Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Bone Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Bone Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Bone Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Bone Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Bone Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Bone Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Bone Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Bone Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Bone Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Bone Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Bone Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Bone Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Bone Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Bone Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Bone Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Bone Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Bone Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Bone Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Bone Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Bone Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Bone Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Bone Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Bone Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Bone Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Bone Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Bone Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Bone Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Bone Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Bone Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Bayer AG Company Details
Table 65. Bayer AG Business Overview
Table 66. Bayer AG Bone Cancer Treatment Product
Table 67. Bayer AG Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 68. Bayer AG Recent Development
Table 69. Amgen Company Details
Table 70. Amgen Business Overview
Table 71. Amgen Bone Cancer Treatment Product
Table 72. Amgen Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 73. Amgen Recent Development
Table 74. Novartis AG Company Details
Table 75. Novartis AG Business Overview
Table 76. Novartis AG Bone Cancer Treatment Product
Table 77. Novartis AG Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 78. Novartis AG Recent Development
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Bone Cancer Treatment Product
Table 82. Pfizer Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 83. Pfizer Recent Development
Table 84. AstraZeneca Company Details
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Bone Cancer Treatment Product
Table 87. AstraZeneca Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 88. AstraZeneca Recent Development
Table 89. Dr. Reddy's Laboratories (DRL) Company Details
Table 90. Dr. Reddy's Laboratories (DRL) Business Overview
Table 91. Dr. Reddy's Laboratories (DRL) Bone Cancer Treatment Product
Table 92. Dr. Reddy's Laboratories (DRL) Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 93. Dr. Reddy's Laboratories (DRL) Recent Development
Table 94. Actavis Company Details
Table 95. Actavis Business Overview
Table 96. Actavis Bone Cancer Treatment Product
Table 97. Actavis Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 98. Actavis Recent Development
Table 99. Bristol-Myers Squibb Company Details
Table 100. Bristol-Myers Squibb Business Overview
Table 101. Bristol-Myers Squibb Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 102. Bristol-Myers Squibb Recent Development
Table 103. Celgene Corporation Company Details
Table 104. Celgene Corporation Business Overview
Table 105. Celgene Corporation Bone Cancer Treatment Product
Table 106. Celgene Corporation Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 107. Celgene Corporation Recent Development
Table 108. Eli Lilly Company Details
Table 109. Eli Lilly Business Overview
Table 110. Eli Lilly Bone Cancer Treatment Product
Table 111. Eli Lilly Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 112. Eli Lilly Recent Development
Table 113. Roche Company Details
Table 114. Roche Business Overview
Table 115. Roche Bone Cancer Treatment Product
Table 116. Roche Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 117. Roche Recent Development
Table 118. GlaxoSmithKline Company Details
Table 119. GlaxoSmithKline Business Overview
Table 120. GlaxoSmithKline Bone Cancer Treatment Product
Table 121. GlaxoSmithKline Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 122. GlaxoSmithKline Recent Development
Table 123. Sanofi Company Details
Table 124. Sanofi Business Overview
Table 125. Sanofi Bone Cancer Treatment Product
Table 126. Sanofi Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 127. Sanofi Recent Development
Table 128. Amneal Pharmaceuticals LLC Company Details
Table 129. Amneal Pharmaceuticals LLC Business Overview
Table 130. Amneal Pharmaceuticals LLC Bone Cancer Treatment Product
Table 131. Amneal Pharmaceuticals LLC Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 132. Amneal Pharmaceuticals LLC Recent Development
Table 133. Baxter International Company Details
Table 134. Baxter International Business Overview
Table 135. Baxter International Bone Cancer Treatment Product
Table 136. Baxter International Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 137. Baxter International Recent Development
Table 138. BoehringerIngelheim Company Details
Table 139. BoehringerIngelheim Business Overview
Table 140. BoehringerIngelheim Bone Cancer Treatment Product
Table 141. BoehringerIngelheim Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 142. BoehringerIngelheim Recent Development
Table 143. Fresenius Kabi Company Details
Table 144. Fresenius Kabi Business Overview
Table 145. Fresenius Kabi Bone Cancer Treatment Product
Table 146. Fresenius Kabi Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 147. Fresenius Kabi Recent Development
Table 148. Jubilant Cadista Pharmaceuticals Company Details
Table 149. Jubilant Cadista Pharmaceuticals Business Overview
Table 150. Jubilant Cadista Pharmaceuticals Bone Cancer Treatment Product
Table 151. Jubilant Cadista Pharmaceuticals Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 152. Jubilant Cadista Pharmaceuticals Recent Development
Table 153. Mylan Pharmaceuticals Company Details
Table 154. Mylan Pharmaceuticals Business Overview
Table 155. Mylan Pharmaceuticals Bone Cancer Treatment Product
Table 156. Mylan Pharmaceuticals Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 157. Mylan Pharmaceuticals Recent Development
Table 158. Perrigo Company Company Details
Table 159. Perrigo Company Business Overview
Table 160. Perrigo Company Bone Cancer Treatment Product
Table 161. Perrigo Company Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 162. Perrigo Company Recent Development
Table 163. Roxane Laboratories Company Details
Table 164. Roxane Laboratories Business Overview
Table 165. Roxane Laboratories Bone Cancer Treatment Product
Table 166. Roxane Laboratories Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 167. Roxane Laboratories Recent Development
Table 168. Sandoz Company Details
Table 169. Sandoz Business Overview
Table 170. Sandoz Bone Cancer Treatment Product
Table 171. Sandoz Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 172. Sandoz Recent Development
Table 173. Henlius Biotech Company Details
Table 174. Henlius Biotech Business Overview
Table 175. Henlius Biotech Bone Cancer Treatment Product
Table 176. Henlius Biotech Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 177. Henlius Biotech Recent Development
Table 178. Teva Pharmaceuticals USA Company Details
Table 179. Teva Pharmaceuticals USA Business Overview
Table 180. Teva Pharmaceuticals USA Bone Cancer TreatmentProduct
Table 181. Teva Pharmaceuticals USA Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 182. Teva Pharmaceuticals USA Recent Development
Table 183. West-Ward Pharmaceuticals Company Details
Table 184. West-Ward Pharmaceuticals Business Overview
Table 185. West-Ward Pharmaceuticals Bone Cancer Treatment Product
Table 186. West-Ward Pharmaceuticals Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 187. West-Ward Pharmaceuticals Recent Development
Table 188. Zydus Pharmaceuticals (Cadila Healthcare) Company Details
Table 189. Zydus Pharmaceuticals (Cadila Healthcare) Business Overview
Table 190. Zydus Pharmaceuticals (Cadila Healthcare) Bone Cancer Treatment Product
Table 191. Zydus Pharmaceuticals (Cadila Healthcare) Revenue in Bone Cancer Treatment Business (2016-2021) & (US$ Million)
Table 192. Zydus Pharmaceuticals (Cadila Healthcare) Recent Development
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bone Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Radiation Therapy Features
Figure 3. Chemotherapy Features
Figure 4. Surgical Treatments Features
Figure 5. Cryosurgery Features
Figure 6. Drugs Features
Figure 7. Global Bone Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 8. Diffuse Bone Cancer Case Studies
Figure 9. Nodular Bone Cancer Case Studies
Figure 10. Necrotizing Bone Cancer Case Studies
Figure 11. Other Case Studies
Figure 12. Bone Cancer Treatment Report Years Considered
Figure 13. Global Bone Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Bone Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Bone Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Bone Cancer Treatment Market Share by Regions (2022-2027)
Figure 17. Global Bone Cancer Treatment Market Share by Players in 2020
Figure 18. Global Top Bone Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bone Cancer Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Bone Cancer Treatment Revenue in 2020
Figure 20. Global Bone Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Bone Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Bone Cancer Treatment Market Share by Type (2016-2027)
Figure 24. North America Bone Cancer Treatment Market Share by Application (2016-2027)
Figure 25. North America Bone Cancer Treatment Market Share by Country (2016-2027)
Figure 26. United States Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Bone Cancer Treatment Market Share by Type (2016-2027)
Figure 30. Europe Bone Cancer Treatment Market Share by Application (2016-2027)
Figure 31. Europe Bone Cancer Treatment Market Share by Country (2016-2027)
Figure 32. Germany Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Bone Cancer Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Bone Cancer Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Bone Cancer Treatment Market Share by Region (2016-2027)
Figure 42. China Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Bone Cancer Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Bone Cancer Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Bone Cancer Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Bone Cancer Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Bone Cancer Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Bone Cancer Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Bone Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Bayer AG Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 62. Amgen Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 63. Novartis AG Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 65. AstraZeneca Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 66. Dr. Reddy's Laboratories (DRL) Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 67. Actavis Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 69. Celgene Corporation Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 70. Eli Lilly Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 71. Roche Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 72. GlaxoSmithKline Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 73. Sanofi Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 74. Amneal Pharmaceuticals LLC Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 75. Baxter International Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 76. BoehringerIngelheim Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 77. Fresenius Kabi Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 78. Jubilant Cadista Pharmaceuticals Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 79. Mylan Pharmaceuticals Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 80. Perrigo Company Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 81. Roxane Laboratories Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 82. Sandoz Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 83. Henlius Biotech Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 84. Teva Pharmaceuticals USA Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 85. West-Ward Pharmaceuticals Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 86. Zydus Pharmaceuticals (Cadila Healthcare) Revenue Growth Rate in Bone Cancer Treatment Business (2016-2021)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
世界の骨肉腫治療市場規模・現状・予測（2021年-2027年） There are diagnostic tests and treatment steps for bone cancer, starting with ultrasound, a CBC, biopsy, and other diagnostic tests.They were then treated with drugs such as corticosteroids, non-steroidal anti-inflammatory drugs and immunosuppressants and surgery.Corticosteroids include difluprednis…- 世界の骨肉腫市場規模・現状・予測（2021年-2027年） Bone cancer can begin in any bone in the body, but it most commonly affects the pelvis or the long bones in the arms and legs. Bone cancer is rare, making up less than 1 percent of all cancers. In fact, noncancerous bone tumors are much more common than cancerous ones. Market Analysis and Insights: …
- 世界の骨肉腫診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Bone Cancer Diagnosis and Therapeutics Market The global Bone Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis a…
- 世界の骨肉腫診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Bone Cancer Diagnosis and Therapeutics Market The global Bone Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis a…
- 世界の骨痛治療市場規模・現状・予測（2021年-2027年） Bone pain is an ache in one or more bones in the body. The pain is generally connected to diseases that influence the normal function or structure of the bone. The major factor that drives the market is the increasing ageing population. There are various causes for bone pain disease such as Injury, …